文献速递关节外科

无菌性全髋关节置换术后脱位需翻修患者的滑膜炎症标志物是否升高

Are Synovial Inflammatory Markers Increased in Patients Who Have Aseptic Total Hip Arthroplasty Dislocation Indicated for Revision?
PubMed 文献 · J Arthroplasty · 2023-08-22

回顾性匹配队列研究纳入55例无菌性全髋关节置换术后脱位需翻修患者与55例因其他原因行无菌翻修患者,按ICM 2018标准检测滑膜炎症标志物。两组滑膜白细胞计数、α-防御素比值及多形核中性粒细胞百分比均无显著差异,脱位组全部患者α-防御素及多形核中性粒细胞百分比均低于截断值。

要点

  • 无菌性全髋脱位翻修患者滑膜白细胞计数、α-防御素比值及多形核中性粒细胞百分比与因其他原因无菌翻修者无显著差异。
  • 脱位组20%患者滑膜白细胞计数≥3,000 c/μL,对照组为18%。
  • 脱位组全部患者α-防御素及多形核中性粒细胞百分比均低于截断值。

核心结论

  • 无菌性全髋关节置换术后脱位患者滑膜炎症标志物与因其他并发症行无菌翻修者相比未见升高。
  • 作者认为,对全髋关节置换术后脱位患者按ICM标准进行详细的术前滑膜炎症标志物分析以排除假体周围关节感染似乎至关重要。

研究设计与样本

  • 回顾性匹配队列研究,证据等级为III级。
  • 纳入55例无菌性全髋关节置换术后脱位需翻修且具备ICM 2018标准术前及术中诊断参数的患者,匹配55例因其他原因行无菌翻修的患者。
  • 两组年龄、性别、BMI及假体固定方式无差异。

主要发现

  • 滑膜白细胞计数:脱位组2,238 ± 2,544 c/μL vs 对照组2,533 ± 3,448 c/μL,P = .601。
  • α-防御素比值:脱位组0.14 ± 0.11 vs 对照组0.19 ± 0.28,P = .207。
  • 多形核中性粒细胞百分比:脱位组36.7 ± 22.6% vs 对照组31.3 ± 24.5%,P = .312。
  • 脱位组20%患者滑膜白细胞计数≥3,000 c/μL,对照组为18%。
  • 脱位组全部患者α-防御素及多形核中性粒细胞百分比均低于截断值。

关键数值与推荐

  • 采用ICM 2018标准进行诊断评估,包括术前及术中参数。
  • 滑膜白细胞计数截断值参考为3,000 c/μL,脱位组20%患者达到或超过该值,对照组18%。

临床怎么用

  • 作者认为,对全髋关节置换术后脱位患者按ICM标准详细分析术前滑膜炎症标志物以排除假体周围关节感染似乎至关重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies have speculated on elevated synovial inflammatory markers in patients undergoing surgical revision for total hip arthroplasty (THA) dislocation. However, this assumption is based on small patient series and a full investigation according to International Consensus Meeting (ICM) criteria has not yet been performed. METHODS: Patients who had aseptic THA dislocation indicated for revision surgery were identified retrospectively. Only patients who had available diagnostic workup according to ICM 2018 criteria, including preoperative and intraoperative parameters, were included. For comparison, we analyzed a matched cohort of patients indicated for aseptic THA revision for other conditions. The 2 cohorts each consisted of 55 patients and were not different regarding age, sex, BMI, or implant fixation. RESULTS: There was no difference in synovial white blood cell count (2,238 ± 2,544 versus 2,533 ± 3,448 c/μL; P = .601), alpha-defensin quotient (0.14 ± 0.11 versus 0.19 ± 0.28; P = .207), or polymorphonuclear neutrophil percentage (% PMN) (36.7 ± 22.6 versus 31.3 ± 24.5%; P = .312) between the groups. In the dislocation cohort, 20% of patients had a synovial white blood cell count of 3,000 c/μL or higher, compared with 18% in the control cohort. However, all patients in the dislocation cohort were below the cutoff for alpha-defensin or % PMN. CONCLUSION: In patients who have aseptic THA dislocation, synovial inflammatory markers are not elevated compared with patients undergoing aseptic revision for other complications. A detailed preoperative analysis of synovial inflammatory markers using ICM criteria appears critical in patients who have a THA dislocation to exclude periprosthetic joint infection. LEVEL OF EVIDENCE: Level III, retrospective, comparative study.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Hubert J, Ritter J, Krüger L, et al. Are Synovial Inflammatory Markers Increased in Patients Who Have Aseptic Total Hip Arthroplasty Dislocation Indicated for Revision? J Arthroplasty. 2023. PMID: 37611677. doi:10.1016/j.arth.2023.08.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。